144 related articles for article (PubMed ID: 4047273)
1. Cefuroxime pharmacokinetics in continuous and intermittent peritoneal dialysis.
Chan MK; Browning AK; Poole CJ; Matheson LA; Li CS; Baillod RA; Moorhead JF
Nephron; 1985; 41(2):161-5. PubMed ID: 4047273
[TBL] [Abstract][Full Text] [Related]
2. The effect of peritonitis on the distribution of cefuroxime in patients undergoing continuous ambulatory peritoneal dialysis.
McIntosh ME; Smith WG; Junor BJ; Forrest G; Brodie MJ
Scott Med J; 1984 Apr; 29(2):117-8. PubMed ID: 6531683
[No Abstract] [Full Text] [Related]
3. Pharmacokinetics of intravenous and intraperitoneal cefuroxime during peritoneal dialysis.
La Greca G; Biasioli S; Chiaramonte S; Fabris A; Feriani M; Pisani E; Ronco C; Xerri L
Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):92-4. PubMed ID: 7061184
[TBL] [Abstract][Full Text] [Related]
4. Oral treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
Searle M; Raman GV
Clin Nephrol; 1985 May; 23(5):241-4. PubMed ID: 4006333
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of intravenous and intraperitoneal cefuroxime in patients undergoing peritoneal dialysis.
Local FK; Munro AJ; Kerr DN; Sussman M
Clin Nephrol; 1981 Jul; 16(1):40-3. PubMed ID: 7273495
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of single daily intraperitoneal administration of aztreonam and cefuroxime in the treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD).
Fuiano G; Sepe V; Viscione M; Nani E; Conte G
Perit Dial Int; 1989; 9(4):273-5. PubMed ID: 2488380
[TBL] [Abstract][Full Text] [Related]
7. The effect of peritonitis on the transperitoneal transport of cefuroxime in patients on CAPD treatment.
Dahl K; Walstad RA; Widerøe TE
Nephrol Dial Transplant; 1990; 5(4):275-81. PubMed ID: 2113224
[TBL] [Abstract][Full Text] [Related]
8. Increased peritoneal permeability in patients with peritonitis undergoing continuous ambulatory peritoneal dialysis.
McIntosh ME; Smith WG; Junor BJ; Forrest G; Brodie MJ
Eur J Clin Pharmacol; 1985; 28(2):187-91. PubMed ID: 3987798
[TBL] [Abstract][Full Text] [Related]
9. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of oral cephradine in continuous ambulatory peritoneal dialysis patients.
Johnson CA; Welling PG; Zimmerman SW
Nephron; 1984; 38(1):57-61. PubMed ID: 6472532
[TBL] [Abstract][Full Text] [Related]
11. Phosphate binders do not reduce bioavailability of oral cefuroxime-axetil in patients on peritoneal dialysis treatment.
Brink HS; Huisman RM; Geerlings W; de Jong PE
Adv Perit Dial; 1994; 10():179-82. PubMed ID: 7999822
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of ceftazidime in patients undergoing peritoneal dialysis.
Tourkantonis A; Nicolaidis P
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():263-7. PubMed ID: 6352629
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of intraperitoneal cefotaxime treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Petersen J; Stewart RD; Catto GR; Edward N
Nephron; 1985; 40(1):79-82. PubMed ID: 4000338
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
Mounier M; Benevent D; Denis F
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):542-4. PubMed ID: 3911152
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of single dose intravenous vancomycin in CAPD peritonitis.
Whitby M; Edwards R; Aston E; Finch RG
J Antimicrob Chemother; 1987 Mar; 19(3):351-7. PubMed ID: 3571051
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis.
Harford AM; Sica DA; Tartaglione T; Polk RE; Dalton HP; Poynor W
Nephron; 1986; 43(3):217-22. PubMed ID: 3724930
[TBL] [Abstract][Full Text] [Related]
17. Flucytosine-miconazole treatment of Candida peritonitis. Its use during continuous ambulatory peritoneal dialysis.
Lempert KD; Jones JM
Arch Intern Med; 1982 Mar; 142(3):577-8. PubMed ID: 7065793
[TBL] [Abstract][Full Text] [Related]
18. Penetration of a prophylactic antibiotic into peritoneal fluid.
Corbett CR; Hollands MJ; Young AE
Br J Surg; 1981 May; 68(5):314-5. PubMed ID: 7225752
[TBL] [Abstract][Full Text] [Related]
19. Peritonitis, a frequently lethal complication of intermittent and continuous ambulatory peritoneal dialysis.
Slingeneyer A; Mion C; Béraud JJ; Oulés R; Branger B; Balmes M
Proc Eur Dial Transplant Assoc; 1981; 18():212-21. PubMed ID: 7329969
[No Abstract] [Full Text] [Related]
20. [Peritonitis in renal failure patients treated by continuous ambulatory peritoneal dialysis. Treatment by intraperitoneal administration of a group M penicillin].
Pierre D; Barthez JP; Geslin N; Calamy G; Borderon E
Presse Med; 1985 Jun; 14(26):1413-6. PubMed ID: 3161046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
